Overview

The Effect of Various Types of the Renin-angiotensin-aldosterone System Blockade on Proteinuria

Status:
Completed
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
The main purpose of the study is to compare the effects of three different types of RAAS blockade on 24 hours proteinuria in patients with non-diabetic chronic kidney disease.
Phase:
Phase 4
Details
Lead Sponsor:
Medical University of Gdansk
Treatments:
Eplerenone
Spironolactone
Telmisartan